Company News
Press Releases
Home Preeclampsia Technology Intellectual property Management News Contact
Please check back frequently for updates on the company’s developments.

Advanced Prenatal Therapeutics - Using Targeted Apheresis to

Treat Preeclampsia

APT, a privately held company, is developing a medical device that will help alleviate the high blood pressure and other symptoms associated with preeclampsia. APT’s targeted apheresis cartridge is expected to be the first medical device specifically designed to treat preeclampsia, a leading cause of maternal and fetal death.

Targeted Therapy for Preeclampsia

Copyright © 2013     Advanced Prenatal Therapeutics, Inc  Terms of Use Privacy Policy
Images courtesy of taoty via
More Info Download News